GenXys provides the world’s most comprehensive precision prescribing software to solve healthcare’s most pressing challenges. Our precision prescribing software and pharmacogenetic solutions prevent adverse drug reactions, a leading cause of death in developed countries, and personalize drug selection to increase drug efficacy. Powering every prescription with our software improves medication safety, increases drug efficacy and reduces healthcare costs.
Mark Gelfer – MD
Dr. Mark Gelfer has more than 20 years of experience on company creation as founder – CMO (VSM MedTech) and product development and commercialization (BpTRU). He is a family physician with a keen interest in innovation of clinical practices and over 30 years of medical experience. His practice is focused on preventive medicine.
Chief Executive Officer
Karl has an international background in healthcare at two multinational pharmaceutical companies and over 15 successful years of launching early-stage software companies and transforming their solutions into ‘best in class’ across diverse industries in the US and globally.
Martin Dawes – MB.BS, MD, FRCGP
Chief Scientific Officer, Co-Founder
Dr. Martin Dawes is a world expert in primary care who combines research and clinical practice with over 30 years of experience. Following the completion of his PhD, he helped develop a Masters program in Evidence Based Health Care. He has directed the UK Centre for Evidence-Based Medicine in Oxford and was the head of family practice at McGill University and the University of British Columbia.
Diana Dawes – MSc, MCSP
Chief Operating Officer
Diana Dawes was one of the leading visionaries behind the establishment of GenXys. She has an MSc in Evidence-Based Health Care from Oxford and is a clinical associate professor at the University of British Columbia. Diana is a successful epidemiologist running clinical trials and synthesizing the best evidence. She helps devise and develop the algorithms that drive TreatGx.
Information Technology Director
David has been designing and building IT systems for over 15 years in both the public and private sectors with a focus on health care. His career started in the NHS, working on clinical audit and decision support systems for diabetes, HIV, cardiac care and other specialities. In Canada, he has worked on systems for the PHSA, CRNBC and BBCSA.
Hagit Katzov-Eckert – PhD
Dr. Hagit Katzov-Eckert received her PhD in genomics from the Karolinska Institute in Stockholm and continued her training in pharmacogenetics as a postdoctoral researcher at the University of British Columbia. Hagit has vast experience in evidence-based methods and genetic testing working in academic and hospital research institutions.
Adriana Suarez-Gonzalez – MSc, PhD
Market Insights Manager
Adriana is passionate about genomics and a supporter of inclusive workplaces. With 10 years of experience in genomics, she facilitates the commercialization of groundbreaking research using marketing and market research tools. Adriana served on the SCWIST B of D, led the creation of the 1st genomics hackathon in Canada and co-founded an outreach program.
Andrea Paterson – BScPharm, RPh
Team Lead & Pharmacogenetic Algorithm Developer
Andrea is a practicing clinical pharmacist at an interdisciplinary primary care clinic in Vancouver. She completed her Bachelor of Pharmacy and post-graduate Community Pharmacy Residency at the University of British Columbia (UBC), and has specialized training in palliative care and chronic pain management. She also lectures in the Faculty of Pharmaceutical Sciences and the Faculty of Medicine – Midwifery Program at UBC.
Lior Shmuel – BSc, MBA, MScB
Senior Software Developer
Lior has an undergraduate degree in computer science and psychology, an MBA degree and an MScB degree from UBC. He has worked as a software developer for more than a decade.
Marysol Garcia-Patino MSc, PhD
Laboratory Manager – Genetics Lab
Marysol is an enthusiastic advocate for better healthcare and well-being. She received a PhD in Pharmaceutical Sciences from the University of British Columbia, and held a postdoctoral fellowship at the same institution. Marysol has specialized in health areas such as cardiovascular disease and diabetes and has a strong background in biotechnology.
Martin Aloise – MSc
Martin is a software developer bridging the gap between software and science. He has years of research experience and holds a Master of Science in biochemistry from McGill University.
Paul Stanley – BSc, BMBS
Pharmacogenetic Algorithm Developer
Paul is an international medical graduate from the University of Limerick with clinical and research experience in Ireland and Canada.
Peter Lin – RPh, MDS
Pharmacogenetic Algorithm Developer
Peter is a pharmacist and a data scientist with an interest in AI/machine learning. He holds a Master of Data Science and a Bachelor of Science in Pharmacy from UBC.
Joe Biegel – BS & MS
Joe brings more than 20 years of executive leadership transforming business problems into market-leading solutions and building strategic, product, and market plans for profitable growth.
Karen Boodram – MBA
Karen has over 25 years of experience in senior roles for both the pharmaceutical industry and capital markets, focusing on commercializing new and innovative health technologies.
Sean Lumb – PhD
Sean has been supporting ventures from ideation to financing and company building for more than 15 years, primarily in the pharmaceutical, chemical and biotech industries.
Jillian Reardon – BScPharm, ACPR, PharmD, RPh
Dr. Reardon is a lecturer and pharmacist with the UBC Faculty of Pharmaceutical Sciences. She has an active primary care practice through the UBC Pharmacists Clinic with research interests in the areas of innovative pharmacy practice and clinical teaching.
Senior Instructor and Director, Community Pharmacy Residency, Faculty of Pharmaceutical Sciences at the University of British Columbia.
THE DIGITAL TECHNOLOGY SUPERCLUSTER has partnered with GenXys to solve some of the most pressing health challenges facing Canada and the world today.
LIFELABS has partnered with GenXys to offer pharmacogenetic testing in Canada.
THE UNIVERSITY OF BRITISH COLUMBIA has licensed the technology
TELUS servers in Canada host our system in a secure environment